MLK Tribute and Inaugural 'Embodiment of Hope Award' Set for Jan. 17

On Jan. 17, UC’s African American Cultural & Resource Center will host the annual Dr. Martin Luther King, Jr., tribute.

The University of Cincinnati African American Cultural & Resource Center will host its annual tribute to Dr. Martin Luther King, Jr., at noon, Thursday, January 17, in The Great Hall, Tangeman University Center.

All are welcome. Doors open at 11:30 a.m. with a reception and light refreshments.

The event will include a presentation of the inaugural MLK Embodiment of Hope Award. This award will recognize a faculty or staff member who daily exemplifies the highest caliber of spirit and service in implementing the vision espoused by Dr. King.

Theme of the event is “Building Intersections of Change: A Global Response to the Dream,” with the keynote address by UC alumna Tamaya Dennard, who earned an International Business degree at the university and currently serves as a Cincinnati City Council member.

Dennard has studied abroad and works as an innovation specialist with Design Impact, a non-profit that partners with hundreds of organizations from Cincinnati to San Diego, tackling complex social challenges as diverse as health disparity, food access, organizational culture, and early education.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.